Involvement of IL-10 in the Autonomous Growth of EBV-Transformed B Cell Lines

Journal of Immunology

Volumn 158, Issue 9, 1997, Pages 4045-4051

  Beatty, P Robert ^a   Krams, Sheri M ^a   Martinez, Olivia M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN RECEPTOR; VIRUS PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL DIVISION; CYTOLOGY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENETICS; HUMAN; LYMPHOPROLIFERATIVE DISEASE; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VIRUS CELL TRANSFORMATION; VIRUS GENE;

B-LYMPHOCYTES; CELL DIVISION; CELL TRANSFORMATION, VIRAL; FLOW CYTOMETRY; GENES, VIRAL; GROWTH SUBSTANCES; HERPESVIRUS 4, HUMAN; HUMANS; INTERLEUKIN-10; LYMPHOPROLIFERATIVE DISORDERS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; VIRAL STRUCTURAL PROTEINS;

EID: 0031135282     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081.
2. Chen, W. F., and A. Zlotnik. 1991. IL-10: A novel cytotoxic T cell differentiation factor. J. Immunol. 147:528.
3. Go, N. F., B. E. Castle, R. Barett, R. Kastelstein, W. Dang, T. R. Mosmann, and M. Howard. 1990. Interleukin-10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625.
4. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165.
5. Levy, Y., and J.-C. Brouet. 1994. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of Bcl-2 protein. J. Clin. Invest. 93:424.
6. Itoh, K., and S. Hirohata. 1995. The role of IL-10 in human B cell activation. proliferation, and differentiation. J. Immunol. 154:4341.
7. Miyazaki, I., R. K. Cheung, and H.-M. Dosch. 1993. Viral interleukin-10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J. Exp. Med. 178:439.
8. Benjamin, D., T. J. Knobloch, and M. A. Dayton. 1992. Human B-cell interleukin-10: B cell lines derived from patients with acquired immmunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80:1289.
9. Burdin, N., C. Peronne, J. Banchereau, and F. Rousset. 1993. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin-10. J. Exp. Med. 177:295.
10. De Waal Malefyt, R., J. Haanen, H. Spits, M.-G. Roncarlo, A. te Velde, C. Figdor, K. Johnson, R. Kastelstein, H. Yssel, and J. E. de Vries. 1991. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915.
11. Ho, M., R. Jaffe, and G. Miller. 1988. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 45:719.
12. Martinez, O. M., J. C. Villaneuva, L. Lawrence-Miyasaki, M. B. Quinn, K. Cox, and S. M. Krams. 1995. Viral and immunologic aspects of Epstein-Barr virus infection in pediatric liver transplant recipients. Transplantation 59:519.
13. Openshaw, P., E. E. Murphy, N. A. Hosken, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1357.
14. Martinez, O. M., N. L. Ascher, L. Ferrell, J. Villanueva, J. Lake, J. P. Roberts, and S. M. Krams. 1993. Evidence for a non-classical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation 55:909.
15. Mohler, K. M., D. S. Torrance, C. A. Smith, R. G. Goodwin, K. E. Stremler, V. P. Fung, H. Madani, and M. B. Widmer. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548.
16. Stewart, J. P., F. G. Behm, J. R. Arrand, and C. M. Rooney. 1994. Differential expression of viral and human interleukin-10 by primary B cell tumors and B cell lines. Virology 200:724.
17. Rousset, F., E. Garcia, T. DeFrance, C. Peronne, N. Vezzio, D. Hsu, R. Kastelstein, K. W. Moore, and J. Banchereau. 1991. Human and viral IL-10 are potent growth and differentiation factors for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89:1890.
18. Thomas, J. A., N. A. Hotchin, M. J. Allday, P. Amlot, M. Rose, M. Yacoub, and D. H. Crawford. 1990. Immunohistology of Epstein-Barr virus-associated antigens in B cell disorders from immunocompromised individuals. Transplantation 49:944.
19. Rochford, R., M. H. Hobbs, J-L. Garnier, N. R. Cooper, and M. J. Cannon. 1993. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. Proc. Natl. Acad. Sci. USA 90:352.
20. Blay, J.-V. N. B., F. Rousset, G. Lenoir, P. Biron, T. Philip, J. Banchereau, and M. C. Favrot. 1993. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 82:2169.
21. Baiocchi, R. A., M. E. Ross, J. C. Tan, C-C. Chou, L. Sullivan, S. Haldar, M. Monne, M. V. Selden, S. K. Narula, J. Sklar, C. M. Croce, and M. A. Caligiuri. 1995. Lymphomagenesis in the SCID-hu mouse involves abundant production of human interleukin-10. Blood 85:1063.
22. Masood, R., Y. Zhang, M. W. Bond, D. T. Scadden, T. Moudgil, R. E. Law, M. H. Kaplan, B. Jung, B. M. Espina, Y. Lunardi-Iskander, A. M. Levine, and P. S. Gill. 1995. Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 85:3423.
23. Randhawa, P., M. Nalesnik, J. Demetris, and A. Zeevi. 1995. Interleukin-10 production by a B-cell line derived from human post-transplant lymphoproliferative disease. Hematol. Oncol. 13:13.
24. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, A. Kuramoto, and T. Kishimoto. 1988. Autocrine generation and requirement of BSF/IL-6 for human multiple myelomas. Nature 332:83.
25. Yokoi, T., T. Miyawaki, A. Yachie, K. Kato, Y. Kasahara, and N. Taniguchi. 1990. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 70:100.
26. Durandy, A., N. Brousse, F. Rozenberg, G. De Saint Basile, A. M. Fischer, and A. Fischer. 1992. Control of human B cell tumor growth in severe combined immunodeficiency mice by monoclonal anti-B cell antibodies. J. Clin. Invest. 90:945.
27. Boussiotis, V., L. M. Nadler, J. L. Strominger, and A. E. Goldfeld. 1994. Tumor necrosis factor. Proc. Natl. Acad. Sci. USA 91:7007.
28. Foa, R., M. Massaia, S. Cardona, A. G. Tos, A. Bianchi, C. Attisano, A. Guarini, P. F. di Celle, and M. T. Fierro. 1990. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of disease. Blood 76:393.
29. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389.
30. Estrov, Z., R. Kurzock, E. Pocsik, S. Pathak, H. M. Kantarjian, T. F. Zipf, D. Harris, M. Talpaz, and B. B. Aggarwal. 1993. Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines. J. Exp. Med. 177:763.